These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37643414)

  • 1. Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience.
    Shabanova V; Emuren L; Gan G; Antwi S; Renner L; Amissah K; Kusah JT; Lartey M; Reynolds NR; Paintsil E;
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):371-380. PubMed ID: 37643414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of non-adherence to antiretroviral therapy among undisclosed HIV-infected children in Ghana.
    Nichols JS; Kyriakides TC; Antwi S; Renner L; Lartey M; Seaneke OA; Obeng R; Catlin AC; Gan G; Reynolds NR; Paintsil E;
    AIDS Care; 2019 Jan; 31(1):25-34. PubMed ID: 30235940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV knowledge, stigma, and illness beliefs among pediatric caregivers in Ghana who have not disclosed their child's HIV status.
    Paintsil E; Renner L; Antwi S; Dame J; Enimil A; Ofori-Atta A; Alhassan A; Ofori IP; Cong X; Kyriakides T; Reynolds NR
    AIDS Care; 2015; 27 Suppl 1(sup1):18-27. PubMed ID: 26616122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana.
    Radcliffe C; Sam A; Matos Q; Antwi S; Amissah K; Alhassan A; Ofori IP; Xu Y; Deng Y; Reynolds NR; Paintsil E;
    BMC Public Health; 2020 Oct; 20(1):1578. PubMed ID: 33081739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of depression among caregivers of children living with HIV in Ghana: findings from the Sankofa pediatric disclosure study.
    Ofori-Atta A; Reynolds NR; Antwi S; Renner L; Nichols JS; Lartey M; Amissah K; Tettey JK; Alhassan A; Ofori IP; Catlin AC; Gan G; Kyriakides TC; Paintsil E;
    AIDS Care; 2019 Mar; 31(3):283-292. PubMed ID: 30360643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinic-Based Pediatric Disclosure Intervention Trial Improves Pediatric HIV Status Disclosure in Ghana.
    Paintsil E; Kyriakides TC; Antwi S; Renner L; Nichols JS; Amissah K; Kusah JT; Alhassan A; Ofori IP; Catlin AC; Gan G; Lartey M; Reynolds NR;
    J Acquir Immune Defic Syndr; 2020 May; 84(1):122-131. PubMed ID: 32049772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study.
    Montalto GJ; Sawe FK; Miruka A; Maswai J; Kiptoo I; Aoko A; Oreyo C; Obiero E; Korir S; Bii SK; Song KX; Kunz AN
    PLoS One; 2017; 12(10):e0183180. PubMed ID: 28991913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.
    Barry O; Powell J; Renner L; Bonney EY; Prin M; Ampofo W; Kusah J; Goka B; Sagoe KW; Shabanova V; Paintsil E
    BMC Infect Dis; 2013 Oct; 13():476. PubMed ID: 24119088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial.
    Ekwunife OI; Anetoh MU; Kalu SO; Ele PU; Eleje GU
    Trials; 2018 Dec; 19(1):710. PubMed ID: 30594223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of, and barriers to the disclosure of HIV status to infected children and adolescents in a district of Ghana.
    Gyamfi E; Okyere P; Enoch A; Appiah-Brempong E
    BMC Int Health Hum Rights; 2017 Apr; 17(1):8. PubMed ID: 28388947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sankofa pediatric HIV disclosure intervention cyber data management: building capacity in a resource-limited setting and ensuring data quality.
    Catlin AC; Fernando S; Gamage R; Renner L; Antwi S; Tettey JK; Amisah KA; Kyriakides T; Cong X; Reynolds NR; Paintsil E
    AIDS Care; 2015; 27 Suppl 1(sup1):99-107. PubMed ID: 26616131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial.
    Ndhlovu CE; Kouamou V; Nyamayaro P; Dougherty L; Willis N; Ojikutu BO; Makadzange AT
    AIDS Res Ther; 2021 Jun; 18(1):32. PubMed ID: 34134738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric HIV Disclosure Intervention Improves Knowledge and Clinical Outcomes in HIV-Infected Children in Namibia.
    Beima-Sofie KM; Brandt L; Hamunime N; Shepard M; Uusiku J; John-Stewart GC; OʼMalley G
    J Acquir Immune Defic Syndr; 2017 May; 75(1):18-26. PubMed ID: 28114186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between HIV diagnosis disclosure and adherence to anti-retroviral therapy among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis.
    Mengesha MM; Teshome A; Ajema D; Tura AK; Hallström IK; Jerene D
    PLoS One; 2023; 18(5):e0285571. PubMed ID: 37167342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of pediatric disclosure among HIV-infected Nigerian children on treatment.
    Odiachi A; Abegunde D
    AIDS Care; 2016 Aug; 28(8):1046-51. PubMed ID: 26883299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.
    Daskalopoulou M; Lampe FC; Sherr L; Phillips AN; Johnson MA; Gilson R; Perry N; Wilkins E; Lascar M; Collins S; Hart G; Speakman A; Rodger AJ;
    AIDS Behav; 2017 Jan; 21(1):184-195. PubMed ID: 27586375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.